NFL BIOSCIENCES SA (ALNFL.PA) Stock Price & Overview
EPA:ALNFL • FR0014003XT0
Current stock price
The current stock price of ALNFL.PA is 1.094 EUR. Today ALNFL.PA is down by -3.19%. In the past month the price decreased by -5.69%. In the past year, price decreased by -32.39%.
ALNFL.PA Key Statistics
- Market Cap
- 13.861M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.36
- Dividend Yield
- N/A
ALNFL.PA Stock Performance
ALNFL.PA Stock Chart
ALNFL.PA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ALNFL.PA. When comparing the yearly performance of all stocks, ALNFL.PA is a bad performer in the overall market: 88.68% of all stocks are doing better.
ALNFL.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALNFL.PA. ALNFL.PA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ALNFL.PA Earnings
ALNFL.PA Forecast & Estimates
11 analysts have analysed ALNFL.PA and the average price target is 2.99 EUR. This implies a price increase of 173.49% is expected in the next year compared to the current price of 1.094.
ALNFL.PA Groups
Sector & Classification
ALNFL.PA Financial Highlights
Over the last trailing twelve months ALNFL.PA reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 54.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -50.64% | ||
| ROE | -84.25% | ||
| Debt/Equity | 0.01 |
ALNFL.PA Ownership
ALNFL.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 25.07 | 37.588B | ||
| 1AE | ARGENX SE | 25.06 | 37.563B | ||
| 22UA | BIONTECH SE-ADR | N/A | 17.926B | ||
| ABVX | ABIVAX SA | N/A | 7.053B | ||
| 2X1 | ABIVAX SA | N/A | 7.037B | ||
| GXE | GALAPAGOS NV | N/A | 1.675B | ||
| GLPG | GALAPAGOS NV | N/A | 1.671B | ||
| NANO | NANOBIOTIX | N/A | 1.282B | ||
| 6IV | INVENTIVA SA | N/A | 1.094B | ||
| IVA | INVENTIVA SA | N/A | 1.038B | ||
| PHIL | PHILOGEN SPA | 18.09 | 660.824M | ||
| GNFT | GENFIT | 815.2 | 415.774M | ||
| FYB | FORMYCON AG | N/A | 312.052M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALNFL.PA
Company Profile
NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. The company is headquartered in Castelnau-Le-Lez, Occitanie and currently employs 4 full-time employees. The company went IPO on 2021-07-05. The firm's products help cure addictions through an approach based on botanical pharmaceutical agents. The company develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The firm applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.
Company Info
IPO: 2021-07-05
NFL BIOSCIENCES SA
199 rue Helene Boucher
Castelnau-le-Lez OCCITANIE FR
Employees: 5
Phone: 33411937667
NFL BIOSCIENCES SA / ALNFL.PA FAQ
Can you describe the business of NFL BIOSCIENCES SA?
NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. The company is headquartered in Castelnau-Le-Lez, Occitanie and currently employs 4 full-time employees. The company went IPO on 2021-07-05. The firm's products help cure addictions through an approach based on botanical pharmaceutical agents. The company develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The firm applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.
What is the stock price of NFL BIOSCIENCES SA today?
The current stock price of ALNFL.PA is 1.094 EUR. The price decreased by -3.19% in the last trading session.
Does ALNFL stock pay dividends?
ALNFL.PA does not pay a dividend.
What is the ChartMill rating of NFL BIOSCIENCES SA stock?
ALNFL.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for NFL BIOSCIENCES SA?
NFL BIOSCIENCES SA (ALNFL.PA) currently has 5 employees.
Can you provide the market cap for NFL BIOSCIENCES SA?
NFL BIOSCIENCES SA (ALNFL.PA) has a market capitalization of 13.86M EUR. This makes ALNFL.PA a Nano Cap stock.
Can you provide the ownership details for ALNFL stock?
You can find the ownership structure of NFL BIOSCIENCES SA (ALNFL.PA) on the Ownership tab.